Replies to post #62849 on Biotech Values

[DewDiligence]

>You don't think that shorter duration might result in better compliance and commercial adoption?<

I think the overall duration of treatment is what matters. VRTX’s “12+12” regimen is still 24 weeks of interferon and 24 weeks of ribavirin.